Summary:
A Randomized, Double-blind, Placebo-controlled, Parallel-group,
Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin
Added to Metformin in Patients with Type 2 Diabetes Mellitus Who
Have Inadequate Glycemic Control on Metformin
Qualified Participants Must:
• Have Type 2 Diabetes
•
Be 18 years of age or older at the screening visit
•
Be treated with diet and exercise and be on metformin
Qualified Participants May Receive:
free study medication; free physical exams; compensation per visit